The legacy success of copyright’s flagship drug has undeniably shaped the pharmaceutical landscape. However, putting money in companies heavily reliant on generic versions and the waning patent exclusivity https://bookmarkspring.com/story16548616/the-blue-pill-and-drugmakers-a-risky-venture